Bill Sponsor
Senate Bill 2739
115th Congress(2017-2018)
Restricting Entrance and Strengthening the Requirements on Import Controls for Trafficking of Illicit Drugs Act
Introduced
Introduced
Introduced in Senate on Apr 24, 2018
Overview
Text
Introduced
Apr 24, 2018
Latest Action
Apr 24, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2739
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Wisconsin
Republican
Louisiana
Democrat
Pennsylvania
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Restricting Entrance and Strengthening the Requirements on Import Controls for Trafficking of Illicit Drugs Act or the RESTRICT Illicit Drugs Act

This bill requires the Food and Drug Administration (FDA)to transfer any packages of illegally imported drugs it receives to the U.S. Customs and Border Protection.

The FDA may (1)debar a person from importing drugs into the United States if they have been convicted of a drug import related felony, and (2)refuse admission of an article imported by someone who is debarred, except that a counterfeit drug must be refused.

Text (1)
April 24, 2018
Actions (2)
04/24/2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
04/24/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:39:39 PM